Photo taken on Oct. 15, 2015 shows artemether tablets and injection for treating malaria disease stored at a health facility in Kawangware slums, Nairobi, capital of Kenya. Africa, a continent continuing to bear the brunt of the burden of malaria, has been one of the biggest beneficiaries of the discovery of artemisinin. According to the World Health Organization (WHO), in 2013, an estimated 163 million cases of malaria occurred in Africa, causing approximately 528,000 deaths.(Xinhua/John Okoyo)
Photo taken on Oct. 15, 2015 shows artemether tablets and injection for treating malaria disease stored at a health facility in Kawangware slums, Nairobi, capital of Kenya. Africa, a continent continuing to bear the brunt of the burden of malaria, has been one of the biggest beneficiaries of the discovery of artemisinin. According to the World Health Organization (WHO), in 2013, an estimated 163 million cases of malaria occurred in Africa, causing approximately 528,000 deaths.(Xinhua/John Okoyo)

Ms Rita Lododnu, HFFG Malaria Project Coordinator for the Region said a cursory observation indicated that most public health facilities, especially in the peri-urban areas are going by the testing, treatment and tracking trends as required by the World Health Organisation (WHO).

Photo taken on Oct. 15, 2015 shows artemether tablets and injection for treating malaria disease stored at a health facility in Kawangware slums, Nairobi, capital of Kenya. Africa, a continent continuing to bear the brunt of the burden of malaria, has been one of the biggest beneficiaries of the discovery of artemisinin. According to the World Health Organization (WHO), in 2013, an estimated 163 million cases of malaria occurred in Africa, causing approximately 528,000 deaths.(Xinhua/John Okoyo)
Photo taken on Oct. 15, 2015 shows artemether tablets and injection for treating malaria disease stored at a health facility in Kawangware slums, Nairobi, capital of Kenya. Africa, a continent continuing to bear the brunt of the burden of malaria, has been one of the biggest beneficiaries of the discovery of artemisinin. According to the World Health Organization (WHO), in 2013, an estimated 163 million cases of malaria occurred in Africa, causing approximately 528,000 deaths.(Xinhua/John Okoyo)

Ms Lodonu was addressing a seminar for nurses and other healthcare providers in Ho on malaria and the WHO protocol.

She said: “So far so good. Checks show that things are getting better. There is a massive improvement.”

Ms Lodonu said the situation is having positive impact on healthcare delivery and urged healthcare providers to stick to the “3Ts”.

She underscored the importance of testing before treatment and urged care givers not to compromise on standard.

Ms Lodonu asked the public to demand the right to be tested before treatment to ensure that they receive the required treatment.

She said HFFG is collaborating with the Ghana Health Service to track information on all reported cases of malaria to ascertain adherence to the treatment protocol.

Ms Lodonu said HFFG with support from the British Department for International Development is sensitising communities and schools on the importance for testing before treatment and the need to use Long Lasting Insecticide Nets.

Source: GNA

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.